You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 3, March 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  SYMPOSIUM ON PROGRESS IN THE TREATMENT OF PORTAL HYPERTENSION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (56)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Emergency Portacaval Shunt Treatment for Bleeding Esophageal Varices

Prospective Study in Unselected Patients With Alcoholic Cirrhosis

Marshall J. Orloff, MD; James G. Chandler, MD; A. Crane Charters, III, MD; James K. Condon, MD; David E. Grambort, MD; Thomas R. Modafferi, MD; Stuart E. Levin, MD

AMA Arch Surg. 1974;108(3):293-299.


Abstract

A prospective evaluation of emergency portacaval shunt has been conducted during a ten-year period in 115 unselected consecutive patients with alcoholic cirrhosis and bleeding esophageal varices. An extensive diagnostic evaluation was completed within seven hours of hospital admission and the shunt operation was undertaken within a mean 8.1 hours. Follow-up was conducted in a special clinic, and the current status of 98.3% of the patients is known. Eighty-two percent of the patients had jaundice, ascites, or encephalopathy alone or in combination on admission. Contrary to recent proposals, patients with the highest portal perfusion pressure and the largest hepatopetal portal blood flow had the highest survival rate, and those who sustained the smallest portal flow diversion from the shunt had the lowest survival rate. The operative survival rate was 48%, the predicted seven-year survival rate was 30%, and the actual seven-year survival rate of 40 patients who were operated on seven or more years ago was 42.5%. In comparisons with our previous prospective studies, emergency portacaval shunt resulted in a significantly greater long-term survival rate than either emergency medical therapy or emergency varix ligation, followed by elective shunt.



Author Affiliations

La Jolla, Calif

From the Department of Surgery, School of Medicine, University of California, San Diego, La Jolla.


Footnotes

Accepted for publication Oct 2, 1973.

Reprint requests to 225 W Dickinson St, San Diego, CA 92103 (Dr. Orloff).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Continuous Intravenous Vasopressin in Active Upper Gastrointestinal Bleeding: A Placebo-Controlled Trial
FOGEL et al.
ANN INTERN MED 1982;96:565-569.
ABSTRACT  

Embolization of Bleeding Esophageal Varices via Umbilical Vein: An Alternative Approach
Sparks et al.
Arch Surg 1982;117:354-358.
ABSTRACT  

Esophagogastric Variceal Hemorrhage: Its Treatment by Percutaneous Transhepatic Coronary Vein Occlusion
Widrich et al.
Arch Surg 1978;113:1331-1338.
ABSTRACT  

A Series of 20 Successful Warren Shunts
Thomford et al.
Arch Surg 1975;110:584-587.
ABSTRACT  

Transthoracoesophageal Ligation of Bleeding Esophageal Varices: A Reappraisal
Wirthlin et al.
Arch Surg 1974;109:688-692.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.